Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy. [electronic resource]
Producer: 20040324Description: 476-8 p. digitalISSN:- 0015-0282
- Alendronate -- administration & dosage
- Bone Density -- drug effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Drug Combinations
- Estradiol -- therapeutic use
- Estriol -- therapeutic use
- Estrogen Replacement Therapy
- Female
- Femur
- Half-Life
- Humans
- Hysterectomy
- Lumbar Vertebrae
- Osteoporosis, Postmenopausal -- drug therapy
- Placebos
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Letter; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.